The first-line antihypertensive nitrendipine potentiated the therapeutic effect of oxaliplatin by downregulating CACNA1D in colorectal cancer
Oxaliplatin (OXA) is among the most common chemotherapy drugs and is the base component of the FOLFOX regimen (OXA + leucovorin + 5-fluorouracil) and CapeOX regimen (OXA + capecitabine). Resistance to and failure of these two OXA-based regimens often results in poor outcomes in patients with colorec...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
De Gruyter
2025-02-01
|
| Reeks: | Open Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1515/med-2024-1138 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|